While there has been no change in law, CMS clarified that anti-obesity medications (AOMs) that receive FDA approval for an additional medically accepted indication can be considered a Part D drug for that specific use
For information on how to find the active ingredients in your medication please go to How to Find Active Ingredients
Retrieved from Ghusn, W., De la Rosa, A., Sacoto, D., et al
Clinicians can also match the 3 mg dose that is approved for obesity by combining the 1.8 mg and 1.2 mg prefilled sizes, but this will increase the cost and require two shots
These effects usually lessen as your body adjusts
Improved Satiety and Appetite Control: Tirzepatide works on multiple hormones, promoting feelings of fullness and reducing hunger, which leads to a decrease in food intake